Form 4 for JSPR Jasper Therapeutics, Inc.
Accepted 2023-04-14 00:00:00 ET · period of report 2023-04-12 · accession 0001213900-23-029896 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-14 | 2023-04-12 | JSPR | MARTELL RON | Pres, CEO, Dir | F - Tax | $1.46 | -87.5K | 418.7K | -17% | -$127.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Stock | 2023-04-12 | F | D | 87,531 | $1.46 | 418,719 | D | — | — | (F1) These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units. |